Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct; 7(10):875-84.

View in: PubMed

subject areas

Aged
Angiotensin II Type 1 Receptor Blockers
Aspirin
Benzimidazoles
Benzoates
Cognition
Dipyridamole
Disability Evaluation
Double-Blind Method
Drug Administration Schedule
Drug Delivery Systems
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
International Cooperation
Male
Mental Status Schedule
Middle Aged
Platelet Aggregation Inhibitors
Retrospective Studies
Secondary Prevention
Severity of Illness Index
Stroke
Ticlopidine

authors with profiles

Yuko Y. Palesch